tetano
Editor, Senior Moderator
Eur J Prev Cardiol. 2020 Apr 15:2047487320918421. doi: 10.1177/2047487320918421. [Epub ahead of print]
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers.
Sarzani R[SUP]1,[/SUP][SUP]2[/SUP], Giulietti F[SUP]1,[/SUP][SUP]2[/SUP], Pentima CD[SUP]1,[/SUP][SUP]2[/SUP], Giordano P[SUP]1[/SUP], Spannella F[SUP]1,[/SUP][SUP]2[/SUP].
Author information
PMID:32290680DOI:10.1177/2047487320918421
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers.
Sarzani R[SUP]1,[/SUP][SUP]2[/SUP], Giulietti F[SUP]1,[/SUP][SUP]2[/SUP], Pentima CD[SUP]1,[/SUP][SUP]2[/SUP], Giordano P[SUP]1[/SUP], Spannella F[SUP]1,[/SUP][SUP]2[/SUP].
Author information
PMID:32290680DOI:10.1177/2047487320918421